{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]HGNC:6547,10,HGNC:6547,156,2]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:6547","source":"HGNC:6547|low density lipoprotein receptor","targets":["GCST000132_5|LDL cholesterol|LDLR|19|4.000000e-26","GCST000134_4|LDL cholesterol|LDLR|19|2.000000e-51","GCST000282_6|LDL cholesterol|LDLR|19|4.000000e-14","GCST000283_4|LDL cholesterol|SMARCA4 - LDLR|19|2.000000e-07","GCST000285_5|Cholesterol, total|LDLR|19|9.000000e-24","GCST000287_2|LDL cholesterol|LDLR|19|2.000000e-26","GCST000340_9|Myocardial infarction (early onset)|SMARCA4|19|2.000000e-09","GCST000533_27|Lipid metabolism phenotypes|LDLR|19|3.000000e-18","GCST000533_29|Lipid metabolism phenotypes|LDLR|19|5.000000e-25","GCST000533_3|Lipid metabolism phenotypes|LDLR|19|1.000000e-25","GCST000533_4|Lipid metabolism phenotypes|LDLR|19|2.000000e-31","GCST000759_25|LDL cholesterol|LDLR|19|4.000000e-117","GCST000760_5|Cholesterol, total|LDLR|19|7.000000e-97","GCST000807_8|LDL cholesterol|LDLR|19|7.000000e-06","GCST000975_11|LDL cholesterol|LDLR|19|7.000000e-08","GCST000998_25|Coronary heart disease|SMARCA4|19|1.000000e-09","GCST001231_11|Carotid intima media thickness|LDLR|19|1.000000e-07","GCST001233_11|Metabolite levels|LDLR|19|2.000000e-12","GCST001247_19|Cardiovascular disease risk factors|LDLR|19|5.000000e-11","GCST001273_2|Lipoprotein-associated phospholipase A2 activity and mass|LDLR|19|3.000000e-11","GCST001392_13|Lipid metabolism phenotypes|SMARCA4|19|8.000000e-17","GCST001639_5|Metabolite levels|LDLR|19|4.000000e-09","GCST002042_3|LDL cholesterol|SMARCA4 - LDLR|19|2.000000e-17","GCST002193_1|Abdominal aortic aneurysm|LDLR|19|2.000000e-10","GCST002220_1|LDL cholesterol|LDLR|19|3.000000e-115","GCST002221_37|Cholesterol, total|LDLR|19|5.000000e-202","GCST002222_7|LDL cholesterol|LDLR|19|4.000000e-262","GCST002287_14|Coronary artery disease or ischemic stroke|SMARCA4|19|3.000000e-12","GCST002289_16|Coronary artery disease|SMARCA4|19|3.000000e-11","GCST002290_4|Coronary artery disease or large artery stroke|SMARCA4|19|2.000000e-11","GCST002896_23|Cholesterol, total|SMARCA4|19|2.000000e-113","GCST002898_4|LDL cholesterol|SMARCA4|19|7.000000e-142","GCST003116_38|Coronary artery disease|SMARCA4|19|4.000000e-15","GCST003117_27|Myocardial infarction|SMARCA4|19|3.000000e-08","GCST003214_14|Cholesterol, total|SPC24|19|2.000000e-16","GCST003216_7|LDL cholesterol|SPC24|19|1.000000e-24","GCST003679_8|C-reactive protein levels or LDL-cholesterol levels (pleiotropy)|CARM1|19|2.000000e-08","GCST003877_5|Abdominal aortic aneurysm|LDLR|19|8.000000e-14","GCST004231_10|Total cholesterol levels|DOCK6|19|7.000000e-11","GCST004233_31|LDL cholesterol levels|SPC24, LDLR|19|3.000000e-15","GCST004235_69|Total cholesterol levels|DOCK6|19|5.000000e-15","GCST004236_6|LDL cholesterol levels|LDLR|19|5.000000e-09","GCST004780_1|Cortisol levels (saliva)|LDLR|19|9.000000e-06","GCST004787_69|Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)|LDLR|19|8.000000e-22","GCST004963_16|Lipoprotein phospholipase A2 activity in cardiovascular disease|LDLR|19|2.000000e-06","GCST005194_123|Coronary artery disease|LDLR|19|5.000000e-41","GCST005194_124|Coronary artery disease|LDLR|19|2.000000e-08","GCST005196_244|Coronary artery disease|LDLR|19|5.000000e-41","GCST006004_20|Low density lipoprotein cholesterol levels|SPC24, LDLR|19|4.000000e-40","GCST006034_28|Total cholesterol levels|SPC24, LDLR|19|8.000000e-49","GCST006612_65|LDL cholesterol|LDLR|19|3.000000e-15","GCST006697_12|Parental longevity (combined parental attained age, Martingale residuals)|LDLR|19|2.000000e-06","GCST007435_5|Carotid plaque|SMARCA4|19|1.000000e-08","GCST007480_1|Disorders of lipid metabolism|SMARCA4 - LDLR|19|3.000000e-10","GCST007688_1|Total cholesterol levels|LDLR|19|2.000000e-06","GCST007689_1|Low density lipoprotein cholesterol levels|LDLR|19|1.000000e-07","GCST007924_2|Medication use (antithrombotic agents)|SMARCA4 - LDLR|19|6.000000e-18","GCST007930_133|Medication use (agents acting on the renin-angiotensin system)|SMARCA4 - LDLR|19|2.000000e-08","GCST007931_29|Medication use (HMG CoA reductase inhibitors)|LDLR|19|8.000000e-116","GCST007931_42|Medication use (HMG CoA reductase inhibitors)|LDLR|19|5.000000e-28","GCST007937_2|Medication use (salicylic acid and derivatives)|SMARCA4 - LDLR|19|6.000000e-15","GCST008037_114|Low density lipoprotein cholesterol levels|LDLR|19|1.000000e-12","GCST008037_21|Low density lipoprotein cholesterol levels|LDLR|19|2.000000e-09","GCST008045_169|Total cholesterol levels|LDLR|19|5.000000e-08","GCST008045_44|Total cholesterol levels|LDLR|19|1.000000e-12","GCST008077_40|LDL cholesterol levels|SMARCA4|19|1.000000e-96","GCST008077_70|LDL cholesterol levels|SMARCA4|19|3.000000e-07","GCST008077_75|LDL cholesterol levels|SMARCA4|19|3.000000e-11","GCST008077_82|LDL cholesterol levels|SMARCA4|19|8.000000e-12","GCST008077_86|LDL cholesterol levels|SMARCA4|19|1.000000e-119","GCST008078_101|LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)|SMARCA4|19|3.000000e-09","GCST008078_105|LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)|SMARCA4|19|4.000000e-11","GCST008078_113|LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)|SMARCA4|19|7.000000e-19","GCST008078_120|LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)|SMARCA4|19|5.000000e-226","GCST008078_9|LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)|SMARCA4|19|2.000000e-193","GCST008079_125|LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|5.000000e-213","GCST008079_138|LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|3.000000e-12","GCST008079_148|LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|4.000000e-13","GCST008079_159|LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|5.000000e-19","GCST008079_76|LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|2.000000e-273","GCST008084_54|HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)|SMARCA4|19|7.000000e-06","GCST008086_1|LDL cholesterol levels in current drinkers|SMARCA4|19|2.000000e-172","GCST008086_15|LDL cholesterol levels in current drinkers|SMARCA4|19|4.000000e-193","GCST008086_49|LDL cholesterol levels in current drinkers|SMARCA4|19|8.000000e-07","GCST008086_51|LDL cholesterol levels in current drinkers|SMARCA4|19|7.000000e-10","GCST008086_9|LDL cholesterol levels in current drinkers|SMARCA4|19|5.000000e-16","GCST008474_20|Peripheral artery disease|SMARCA4 - LDLR|19|1.000000e-10","GCST009240_115|Serum metabolite levels (CMS)|LDLR|19|1.000000e-11","GCST009240_12|Serum metabolite levels (CMS)|LDLR|19|2.000000e-12","GCST009240_138|Serum metabolite levels (CMS)|LDLR|19|5.000000e-15","GCST009240_200|Serum metabolite levels (CMS)|LDLR|19|7.000000e-11","GCST009240_205|Serum metabolite levels (CMS)|LDLR|19|1.000000e-09","GCST009240_211|Serum metabolite levels (CMS)|LDLR|19|1.000000e-11","GCST009240_220|Serum metabolite levels (CMS)|LDLR|19|4.000000e-10","GCST009240_232|Serum metabolite levels (CMS)|LDLR|19|4.000000e-12","GCST009240_240|Serum metabolite levels (CMS)|LDLR|19|3.000000e-12","GCST009240_246|Serum metabolite levels (CMS)|LDLR|19|2.000000e-14","GCST009240_253|Serum metabolite levels (CMS)|LDLR|19|3.000000e-10","GCST009240_265|Serum metabolite levels (CMS)|LDLR|19|9.000000e-15","GCST009240_278|Serum metabolite levels (CMS)|LDLR|19|2.000000e-11"]}]}